Nobel Prize-winning endocrine oncologist Andrew V. Schally, Ph.D., M.D., who earned the prestigious award in 1977 for his work in neuroendocrinology, will deliver the annual Harry Mullin, M.D., Lecture at The University of Scranton on Thursday, Nov. 11, at 8 p.m., in the Houlihan-McLean Center.

Dr. Schally’s discovery of hypothalamic hormones laid the foundation for modern endocrinology. His subsequent work on hormone-dependent tumors and in developing peptide analogs for cancer treatment led to clinical research and a therapy for prostate cancer that is used today. Thousands of cancer patients worldwide are benefiting from Dr. Schally’s pioneering work.

Listed as the most cited author in the field of endocrinology in 1978, Dr. Schally is the author or coauthor of more than 2,300 publications, including articles, abstracts, reviews and books. He has earned 33 awards and 22 honorary degrees and is a member of more than 40 scientific organizations worldwide.

Currently, Dr. Schally is continuing his research on the control of cancer and other diseases as Chief of the Endocrine, Polypeptide and Cancer Institute at the Veterans Affairs Medical Center in Miami, Fla. He is also a distinguished medical research scientist at the Department of Veterans Affairs and a distinguished miller professor of pathology and professor of medicine in the Division of Hematology/Oncology at the University of Miami’s Miller School of Medicine, Miami, Fla.

The Mullin Lecture series, which has brought to campus some of the world’s most distinguished scholars and scientists, including more than a dozen Nobel laureates, honors the late Dr. Harry Mullin, who earned his bachelor’s degree from the University, then St. Thomas College, in 1931. He dedicated a lifetime of service to his profession and the Scranton community. The series is sponsored by his wife, Ethel Mullin, his son, Brian Mullin, M.D., ’66, and Robbin Mullin.

For additional information about the lecture, which is free and open to the public, call 941-5873.